Keyword: Peptides

News

CordenPharma Completes Upgrade of US Peptide Production Site in Colorado

06.09.2023 -

CDMO CordenPharma, a specialist in active pharmaceutical ingredients (APIs), excipients, drug products and packaging services, inaugurated an increased commercial peptide...

News

Bachem Inks $531 Million Peptides Manufacturing Deal

08.03.2023 -

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has signed another order worth more than 500 million Swiss francs – or $531...

News

Croda Acquires South Korean Biotech Firm

08.02.2023 -

UK specialty chemicals company Croda International has agreed to buy Solus Biotech, a South Korean company specializing in ceramide and phospholipid technologies and with...

Chemistry & Life Sciences

Ensuring API Supply Capacities for Europe and Beyond

13.10.2022 -

Interview with Karl Rotthier, CEO of the Sanofi spin-off EuroAPI.

News

Bachem Buys DSM’s Sisslerfeld Site

10.10.2022 -

Swiss peptide and oligonucleotide specialist Bachem has agreed to buy an undeveloped site in Sisslerfeld from DSM. It has completed the purchase of a first plot, with...

News

Bachem Secures Major Peptide Contracts

22.09.2022 -

Bachem, a Swiss specialist developer and manufacturer of peptides and oligonucleotides, has announced the signing of two major contracts for supplying large volumes of...

Chemistry & Life Sciences

Expanding Into Oligonucleotides

04.12.2020 -

The global market for oligonucleotide therapeutics is expanding rapidly. Bachem, an innovation-driven company based in Bubendorf, Switzerland, has entered this...

Strategy & Management

The Importance of Innovation for Future Success

16.09.2020 -

Innovative strength has been a cornerstone of Bachem’s business success since the founding nearly 50 years ago. Günther Loidl, Chief Technology Officer for Bachem Holding...